MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Immuron Limited P/E | IMRN
P/E Jährlich Immuron Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -44.3 | -32.8 | -60.2 | -191 | - | - | -70.2 | -238 | -128 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.8 | -238 | -109 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Immunic
IMUX
|
-1.49 | $ 7.28 | -1.75 % | $ 1.13 B |  USA |
 |
Immunovant
IMVT
|
-12.8 | $ 28.19 | -0.79 % | $ 5.14 B | USA |
 |
INmune Bio
INMB
|
-0.614 | $ 1.43 | -2.05 % | $ 35.4 M | USA |
 |
Insmed Incorporated
INSM
|
-24.8 | $ 93.44 | 0.05 % | $ 18.6 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
-33.9 | $ 43.42 | 1.13 % | $ 6.95 B | USA |
 |
Innate Pharma S.A.
IPHA
|
-2.57 | $ 1.47 | -1.64 % | $ 132 M |  France |
 |
Ironwood Pharmaceuticals
IRWD
|
4.18 | $ 3.49 | 0.87 % | $ 565 M | USA |
 |
Inventiva S.A.
IVA
|
-0.996 | $ 3.67 | -1.08 % | $ 219 M | France |
 |
Jazz Pharmaceuticals plc
JAZZ
|
-29.6 | $ 205.67 | -3.89 % | $ 12.5 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
26.9 | $ 266.51 | 1.02 % | $ 642 B | USA |
 |
Kamada Ltd.
KMDA
|
24.3 | $ 7.93 | 2.06 % | $ 457 M |  Israel |
 |
Krystal Biotech
KRYS
|
41.3 | $ 313.53 | 0.65 % | $ 9.07 B | USA |
 |
Kura Oncology
KURA
|
-2.64 | $ 9.64 | 0.31 % | $ 845 M | USA |
 |
Kymera Therapeutics
KYMR
|
25.5 | $ 114.86 | 3.7 % | $ 9.7 B | USA |
 |
Lineage Cell Therapeutics
LCTX
|
-6.63 | $ 1.0 | -0.1 % | $ 230 M | USA |
 |
Nanobiotix S.A.
NBTX
|
-60.6 K | $ 31.65 | 7.8 % | $ 1.51 T | France |
 |
Longeveron
LGVN
|
-743 | $ 1.61 | 0.62 % | $ 28.3 B | USA |
 |
Eli Lilly and Company
LLY
|
45.6 | $ 1 277.31 | 0.3 % | $ 1.15 T | USA |
 |
Lipocine
LPCN
|
-1.86 | $ 1.43 | -0.69 % | $ 7.79 M | USA |
 |
Larimar Therapeutics
LRMR
|
-2.24 | $ 2.22 | -5.53 % | $ 184 M | USA |
 |
vTv Therapeutics
VTVT
|
-5.18 | $ 25.97 | 1.64 % | $ 103 M | USA |
 |
Moleculin Biotech
MBRX
|
-0.0734 | $ 6.9 | 6.12 % | $ 8.17 M | USA |
 |
MacroGenics
MGNX
|
-2 K | $ 2.17 | -3.56 % | $ 137 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
-2.29 K | $ 0.64 | -0.88 % | $ 68 M |  Canada |
 |
Merck & Co.
MRK
|
17 | $ 140.44 | -3.32 % | $ 351 B | USA |
 |
Moderna
MRNA
|
-6.88 | $ 197.65 | -1.23 % | $ 76.9 B | USA |
 |
Adial Pharmaceuticals
ADIL
|
-0.164 | $ 3.73 | -4.97 % | $ 2.49 M | USA |
 |
Revolution Medicines
RVMD
|
-17.3 | $ 183.82 | -1.7 % | $ 34.9 B | USA |
 |
Akari Therapeutics, Plc
AKTX
|
-467 | $ 7.99 | -2.86 % | $ 538 B |  Britain |
 |
Alector
ALEC
|
-1.73 | $ 1.83 | -0.27 % | $ 188 M | USA |
 |
Aligos Therapeutics
ALGS
|
-2.73 | $ 4.55 | -4.81 % | $ 45 M | USA |
 |
Alkermes plc
ALKS
|
21.2 | $ 44.42 | 1.8 % | $ 7.32 B | Irlanda |
 |
Allogene Therapeutics
ALLO
|
-2.85 | $ 1.22 | -2.8 % | $ 269 M | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-23.7 | - | -7.31 % | $ 49 M | USA |
 |
Amgen
AMGN
|
25.7 | $ 444.7 | 1.24 % | $ 239 B | USA |
 |
Amarin Corporation plc
AMRN
|
-150 | $ 12.13 | 2.88 % | $ 5.03 B | Irlanda |
 |
Amneal Pharmaceuticals
AMRX
|
59.8 | $ 21.07 | 3.39 % | $ 6.6 B | USA |
 |
AnaptysBio
ANAB
|
12.1 | $ 48.78 | 0.1 % | $ 1.41 B | USA |
 |
Aclaris Therapeutics
ACRS
|
-5.93 | $ 3.77 | 0.4 % | $ 462 M | USA |
 |
AC Immune SA
ACIU
|
-4.08 | $ 2.3 | -4.96 % | $ 232 M |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
-7.3 | - | - | $ 1.77 B | USA |
 |
Adagene
ADAG
|
-12.7 | $ 2.49 | 3.32 % | $ 147 M |  China |
 |
ADMA Biologics
ADMA
|
25.7 | $ 11.05 | 3.46 % | $ 2.63 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
-41.7 | $ 26.3 | 3.1 % | $ 3.99 B | USA |
 |
Agenus
AGEN
|
-31.7 | $ 6.19 | -2.21 % | $ 184 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
-3.95 | $ 36.67 | -0.91 % | $ 2.13 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-25.3 | $ 4.2 | 0.12 % | $ 805 M | Canada |
 |
ADC Therapeutics SA
ADCT
|
-0.971 | $ 1.51 | 4.51 % | $ 192 M | Schweiz |
 |
AbbVie
ABBV
|
220 | $ 286.99 | 0.47 % | $ 508 B | USA |